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• Background to data sharing
• Current guidance
• Our work on anonymization













• Usually at the end of the study
• Sharing data with unspecified secondary researchers




• Anonymization and deidentification used 
interchangeably
• “information which does not relate to an identified or 
identifiable natural person or to personal data 
rendered anonymous in such a manner that the data 
subject is not or no longer identifiable” [Recital 26]




Trial ID Date of Enrolment Initials Date of Birth Postcode Gender
1001 04/05/2012 JB 05/04/1945 EH1 2AQ M
1002 05/05/2012 AS 26/07/1956 OX4 4XP M
1003 12/05/2012 MM 01/08/1940 IP2 4AY M
1004 14/05/2012 EW 21/04/1926 SW1A 1AA F
1005 19/05/2012 MS 03/09/1930 KT6 7XY F
1006 19/05/2012 TR 11/12/1933 EH4 2XU M
1007 21/05/2012 AW 07/01/1947 IP3 1LE F
XXXX XXXX XXXX XXXX XXXX XXXX
XXXX XXXX XXXX XXXX XX XXXX
XXXX XXXX XXXX XXXX XXXX XXXX
XXXX XXXX XXXX XXXX XXXX XXXX
XXXX XXXX XXXX XXXX XXX XXXX
XXXX XXXX XXXX XXXX XXX XXXX
XXXX XXXX XXXX XXXX XXXX XXXX
Age at 
Enrolment
A 45 67 EH1
A 56 OX
A3 0 72 IP2
A187 86 SW1A
A238 82 KT6









• Aimed at CTUs
• Recommends a controlled access 
model
• Published April 2015
Good Practice Principles for Sharing Individual 
Participant Data from Publicly Funded Clinical Trials. 
Tudur Smith C, Hopkins C, Sydes M, Woolfall K, Clarke 













• What to remove?
• 28 participant identifiers (Hrynaszkiewicz & 
colleagues)







Direct Identifiers Indirect Identifiers
Name Place of treatment 
Initials Sex
Address, including full or partial postal 
code
Rare disease or treatment
Dates related to an individual (inc.
date of birth)
Year of birth or age
Unique identifying numbers Small denominators - population size 
of <100 





• What to remove?
• 28 participant identifiers (Hrynaszkiewicz & 
colleagues)
• Both direct and indirect identifiers to consider








• Assess data variables & assign value
• Decide on anonymisation method for direct identifiers
2nd Pass
• Determine indirect identifier risk
• Decide on anonymisation method for high risk indirect identifiers
Test






• Variables coded and assigned value
• Direct identifiers 01-14 (+15, superfluous)
• Indirect identifiers A-N
• 1st pass of data dictionary
• Either direct/superfluous, indirect, or not requiring 
modification
• Direct identifiers – assign method of anonymization









SubjectNo Subject Number. int Y 06 Recode
AEDescription description of the AE int ? C, N
Surgery int ? C
StartDD Start Date (day) varchar Y 14 Study day
StartMMM Start Date (month) varchar Y 14 Study day
StartYYYY Start Date (year) varchar Y 14 Study day
AECategory ID int N
Reason code 06 = Unique identifying number
Reason code 14 = Dates related to an individual
Reason code C = Rare disease or treatment




• Use date of randomisation as day 0
• All other dates relative to date of randomisation
• e.g. date of randomisation 15/01/2014, start date of 
AE 16/01/2014





• Indirect identifiers – decision to anonymise or leave 
alone
• Currently use a consensus model
• Some summarized to determine risk (event counts)
• May need medical input
@EdinUniUsher 
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SubjectNo Subject Number. int Y 06 Recode
AEDescription description of the AE int ? C, N
Surgery int ? C
StartDD Start Date (day) varchar Y 14 Study day
StartMMM Start Date (month) varchar Y 14 Study day
StartYYYY Start Date (year) varchar Y 14 Study day
AECategory ID int N
2nd pass example
Y on 2nd pass
N on 2nd pass
Reason code 06 = Unique identifying number
Reason code 14 = Dates related to an individual
Reason code C = Rare disease or treatment




• Is it anonymous?
• Motivated intruder test
• May not be required for every dataset (risk based 
approach)
• Is it useful?
• Re-run analysis with modified dataset




• Generic rules can be created for direct identifiers
• Decisions on indirect identifiers on a trial-by-trial 
basis








• Standard form (credentials, research question)
Review
• Committee review (ECTU + Chief Investigator)
Contract
• Data Access Agreement
Release
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Questions?
• Thanks to:
